InSphero AG
InSphero has been founded on March 26th, 2009 in Zurich by the BEL collaborator Dr. Jan Lichtenberg, as well as Dr. Jens Kelm (ETH and University of Zurich) and Dr. Wolfgang Moritz (University of Zurich).
InSphero develops and produces advanced 3-dimensional microtissue models that mimick the behavior and function of living organs much better than conventional cell cultures. InSphero offers ready-to-use microtissues, microtissue assays, and 3D cell-culture solutions, which are compatible with existing laboratory liquid-handling robotics. A production capacity of more than 10’000 microtissues per day and cell line is anticipated. The costs are on the order of standard monolayer cultures.
The microtissues enable more reliable and relevant screening and validation processes for the development of drugs and biopharmaceuticals. Therefore, the main applications areas include:
- Pharmascreening
- Diagnostics and medical therapy
InSphero is an official ETH spin-off and was supported by the Swiss Commission of Technology and Innovation, external pageCTI , the external pageSwiss Volkswirtschaftsstiftung, the external pageVenture Kick business competition and private initiatives.
Open Positions:
You enjoy working at the cutting edge of science and technology? Then, Insphero may have a position for you. Just have a look at their external pageopen positions.
